Research Fees. Licensee shall pay to SGI the following amounts in consideration of the Research Program:
6.1.1 Within ten (10) business days of the Effective Date, Licensee shall pay to SGI the sum of Two Million U.S. Dollars ($2,000,000) by wire transfer of immediately available funds (the “ADC Access Fee”).
6.1.2 Licensee shall pay SGI at an annual rate of [***] per FTE who provides assistance as requested by Licensee pursuant to this Agreement in each of the first [***] of the Term (the “FTE Fees”). Commencing upon the [***] of the Effective Date (the “[***]”) and [***] Confidential treatment has been requested with respect to the omitted portions. upon [***] thereafter, the FTE Fees will [***] by [***] per FTE per year; provided, that, notwithstanding the foregoing, the Parties hereby agree that Licensee shall pay no consideration to SGI in connection with any preparation of ADCs or related characterization work performed by SGI under the Initial Agreements. Licensee shall also pay SGI for all Drug Conjugation Materials supplied by SGI to Licensee hereunder at the rate of [***] of SGI’s Cost of Goods therefor (the “Supply Fees”). The FTE Fees and the Supply Fees are collectively referred to herein as (the “Research Fees”). Within [***] after the end of each [***], SGI shall submit a report to Licensee supporting the calculation of the Research Fees due for such [***] (a “Research Fees Report”). Licensee shall pay all Research Fees to SGI within [***] of receipt of each Research Fees Report.
Research Fees. Merck will pay Mersana at the annual fully loaded FTE Rate, for each FTE who performs Development, consultation or support work under the applicable Research Plan or this Agreement (including pursuant to Section 4.3.1, Section 4.3.3, and Section 5.1.2), which FTE Rate shall include the cost of routine lab supplies and materials used by such FTEs in such Development, consultation or support work (the “FTE Fees”). Merck shall also pay Mersana for all non-routine supplies and materials used by Mersana in the performance of activities under the applicable Research Plan and amounts paid to Third Parties (including consultants, vendors and suppliers) performing activities on behalf of Mersana under the Research Plan (including out-of-pocket costs pursuant to Section 4.3.1, Section 4.3.3, and Section 5.1.2), in each case, at the actual and verifiable out-of-pocket costs to Mersana therefor (the “Supply Fees”); provided that any such Supply Fees are included in the budget that is included within the applicable Research Plan approved pursuant to Section 2.5.2.2(b). The FTE Fees and the Supply Fees are collectively referred to herein as the “Research Fees.”
Research Fees. At Payment World’s sole discretion, You may also be charged a Chargeback Research Fee of fifty dollars ($50.00) per chargeback. Payment World reserves the right to charge for and collect said fees up to and including termination of the Agreement.
Research Fees. (a) Within thirty (30) days after the Effective Date Roche will pay to SGX a non-refundable, non-creditable upfront fee of $[...***...].
(b) During the Term of the Collaboration, Roche will pay to SGX research payments of $[...***...] per calendar quarter, payable on the first day of each calendar quarter, commencing on the Effective Date.
Research Fees. 3.1.1 In consideration of BioFocus performing the Services, the Client shall pay to BioFocus the amounts described or referred to in the relevant Schedule of Work, in accordance with the provisions of that Schedule of Work (“Research Fees”).
3.1.2 BioFocus may elect to increase the Research Fees, including any FTE Rates, once in any 12-month period. BioFocus shall give the Client not less than one (1) months’ notice of any increase in the Research Fees. Any such increase should not exceed the percentage increase, over the last 12 months for which figures are available, in the UK All Items Retail Prices Index. Any increase in the Research Fees will apply with effect from the expiry of BioFocus’ notice.
Research Fees. During the Collaborative Period, Firmenich will pay Senomyx annual research fees of […***…] for the Collaborative Program including the activities performed pursuant to the Research Plan (“Research Fees”). These payments will be made in advance in equal quarterly installments in the amount of […***…]. The first payment of […***…] will be made within […***…] following the Effective Date. In addition to the foregoing, Firmenich and Senomyx have agreed that at the first meeting of the Steering Committee following the Effective Date of this Agreement, the parties will discuss […***…]. Such discussion shall include a consideration of […***…] and other related details for the […***…], including […***…].
Research Fees. Adesto shall timely pay to Axon, [*] in advance, for the first [*] of the Term commencing with the Investment Date and thereafter on the anniversary of the Investment Date and within [*] of such a date, the following Research Fees: YEAR RESEARCH FEE Upon Investment Date [*] Second Year after Investment Date [*] Third Year after Investment Date [*] Fourth Year after Investment Date [*] Fifth Year after Investment Date [*]
Research Fees. On the Effective Date Glaxo will pay MEGABIOS[ * ]and ------------- on the first days of July and October in 1994, and on the first days of January, April, July and October of up to and including October 1, 1998, Glaxo will pay MEGABIOS[ * ] for research to be conducted by MEGABIOS under Section 2.1.
Research Fees. For research that Borrower requests on its Loan (unless such research discloses a billing error made by the Bank), there will be research and copying charges in the standard amounts set by the Bank and available in each branch office (which amounts will be added to and included in the Outstanding Balance).
